Scientific Sessions 2025  /  Controversies in Lifetime Management of Aortic Stenosis Patients Under 65 years: TAVR vs SAVR First Strategy  /  Survival Is Key: Ross Operation
Logo

American Heart Association

  38
  0

Final ID:

Survival Is Key: Ross Operation

  • El-hamamsy, Ismail  ( Mount Sinai Hospital , New York , New York , United States )
  • Boskovski, Marko  ( UCSF , Boston , Massachusetts , United States )
  • Tseng, Elaine  ( UCSF and SFVA , South San Francisco , California , United States )
    • Author Disclosures:
    Ismail El-Hamamsy: DO NOT have relevant financial relationships | Marko Boskovski: DO have relevant financial relationships ; Consultant:Edwards Lifesciences:Active (exists now) | Elaine Tseng: DO have relevant financial relationships ; Research Funding (PI or named investigator):Amgen:Past (completed) ; Research Funding (PI or named investigator):Portrero Med:Past (completed) ; Research Funding (PI or named investigator):Cellphire:Past (completed)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Controversies in Lifetime Management of Aortic Stenosis Patients Under 65 years: TAVR vs SAVR First Strategy

Saturday, 11/08/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
One and Done: Mechanical SAVR for Lifetime Management

Preventza Ourania, Goldstone Andrew, Bowdish Michael, Ouzounian Maral, Woo Y Joseph, Chikwe Joanna, Forcillo Jessica

Is TAVR Increasing in the Young and What are the Outcomes?

Forcillo Jessica, Eltchaninoff Helene, Preventza Ourania, Ouzounian Maral

More abstracts from these authors:
We have options: The surgical approach to the ACHD patient with Aortic Valve Disease

Starnes Vaughn, El-hamamsy Ismail

Viewpoints: Ross Procedure Optimizes Life-Time Survival

El-hamamsy Ismail, Boskovski Marko, Bavaria Joseph, Fukuhara Shinichi

You have to be authorized to contact abstract author. Please, Login
Not Available